Trial record 9 of 16 for:    Ad26.ZEBOV

A Study to Assess Safety Tolerability and Immunogenicity of Three Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02416453
Recruitment Status : Completed
First Posted : April 15, 2015
Last Update Posted : March 9, 2018
Information provided by (Responsible Party):
Janssen Vaccines & Prevention B.V.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 19, 2018
  Actual Study Completion Date : January 19, 2018